{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:57:52Z","timestamp":1786978672632,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":10,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_14","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:01:40Z","timestamp":1753707700000},"page":"209-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guide to Selection of Muscle-Homing Peptides After in Vivo Phage Display Biopanning"],"prefix":"10.1007","author":[{"given":"Anne-Fleur","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Jirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1471-2105-8-280","volume":"8","author":"T Shtatland","year":"2007","unstructured":"Shtatland T, Guettler D, Kossodo M, Pivovarov M, Weissleder R (2007) PepBank \u2013 a database of peptides based on sequence text mining and public peptide data sources. BMC Bioinformatics 8:280","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"14_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ab.2011.11.005","volume":"421","author":"PA \u2018t Hoen","year":"2012","unstructured":"\u2018t Hoen PA, Jirka SM, Ten Broeke BR, Schultes EA, Aguilera B, Pang KH, Heemskerk H, Aartsma-Rus A, van Ommen GJ, den Dunnen JT (2012) Phage display screening without repetitious selection rounds. Anal Biochem 421(2):622\u2013631. https:\/\/doi.org\/10.1016\/j.ab.2011.11.005","journal-title":"Anal Biochem"},{"issue":"2","key":"14_CR3","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/molecules16021776","volume":"16","author":"R Derda","year":"2011","unstructured":"Derda R, Tang SK, Li SC, Ng S, Matochko W, Jafari MR (2011) Diversity of phage-displayed libraries of peptides during panning and amplification. Molecules 16(2):1776\u20131803","journal-title":"Molecules"},{"issue":"1","key":"14_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A (2021) Duchenne muscular dystrophy. Nat Rev Dis Primers 7(1):13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3","journal-title":"Nat Rev Dis Primers"},{"issue":"26","key":"14_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015858","volume":"98","author":"LN Alfano","year":"2019","unstructured":"Alfano LN, Charleston JS, Connolly AM, Cripe L, Donoghue C, Dracker R, Dworzak J, Eliopoulos H, Frank DE, Lewis S, Lucas K, Lynch J, Milici AJ, Flynt A, Naughton E, Rodino-Klapac LR, Sahenk Z, Schnell FJ, Young GD, Mendell JR, Lowes LP (2019) Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine (Baltimore) 98(26):e15858","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"14_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.24555","volume":"79","author":"JR Mendell","year":"2016","unstructured":"Mendell JR, Goemans N, Lowes LP, Alfano LN, Berry K, Shao J, Kaye EM, Mercuri E (2016) Eteplirsen study group and Telethon Foundation DMD Italian network. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol 79(2):257\u2013271","journal-title":"Ann Neurol"},{"issue":"21","key":"14_CR7","doi-asserted-by":"publisher","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","volume":"94","author":"DE Frank","year":"2020","unstructured":"Frank DE, Schnell FJ, Akana C, El-Husayni SH, Desjardins CA, Morgan J, Charleston JS, Sardone V, Domingos J, Dickson G, Straub V, Guglieri M, Mercuri E, Servais L, Muntoni F (2020) SKIP-NMD study group. Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy. Neurology 94(21):e2270\u2013e2282. https:\/\/doi.org\/10.1212\/WNL.0000000000009233","journal-title":"Neurology"},{"issue":"10","key":"14_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1358\/dot.2019.55.10.3045038","volume":"55","author":"RR Roshmi","year":"2019","unstructured":"Roshmi RR, Yokota T (2019) Viltolarsen for the treatment of Duchenne muscular dystrophy. Drugs Today (Barc) 55(10):627\u2013639. https:\/\/doi.org\/10.1358\/dot.2019.55.10.3045038","journal-title":"Drugs Today (Barc)"},{"issue":"8","key":"14_CR9","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","volume":"28","author":"AJ Debacker","year":"2020","unstructured":"Debacker AJ, Voutila J, Catley M, Blakey D, Habib N (2020) Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug. Mol Ther 28(8):1759\u20131771. https:\/\/doi.org\/10.1016\/j.ymthe.2020.06.015","journal-title":"Mol Ther"},{"key":"14_CR10","unstructured":"Ph.D.\u2122 Phage Display Libraries, New England Biolabs, Inc. https:\/\/international.neb.com\/-\/media\/nebus\/files\/manuals\/manuale8100_e8101_e8110_e8111_e8120.pdf?rev=b9782324ddd14d489da1db10e9240e60&hash=376964EEC6D44C1B6EC60B9A60A652AF"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:08:56Z","timestamp":1780747736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}